TALTZ

eli lilly canada inc🇨🇦 Health Canada

Approval Id: 585be1614e54ba94
Drug Approval Canada Name: TALTZ
Product Name: TALTZ
Status: Marketed
Status Date: 2023-04-12
Original Market Date: 2016-08-11
Din: 02455110
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Subcutaneous
Schedule: Schedule D , Prescription
Ahfs: 90:24.20.92
Atc Original: L04AC13 IXEKIZUMAB
Atc Name: l 04 ac 13
Aig Number: 0158170001
Company Name: eli lilly canada inc
Company Address: SUITE 900, Exchange Tower, 130 King Street West, Toronto, Ontario, Canada, M5X 1B1

IXEKIZUMAB

80 MG / ML

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

585be1614e54ba94

Type

Standard